Literature DB >> 10334923

In vivo interaction of AF-6 with activated Ras and ZO-1.

T Yamamoto1, N Harada, Y Kawano, S Taya, K Kaibuchi.   

Abstract

AF-6 contains two putative Ras-associating domains (RA domains) which are seen in several Ras effectors such as RalGDS and RIN1. We previously showed that an AF-6 fragment containing the amino-terminal (N-terminal) RA domain directly binds to activated Ras and ZO-1 in vitro. In this study, we showed that a single amino acid mutation in the N-terminal RA domain of AF-6 abolished the interaction of AF-6 with activated Ras and that the sites of this critical amino acid residue were similar to those for Raf-1 and RalGDS. The overexpression of the N-terminal RA domain of AF-6 inhibited the Ras-dependent c-fos promoter/enhancer stimulation in NIH3T3 cells. Endogenous AF-6 was coimmunoprecipitated with activated Ras from Rat1 cells expressing activated Ras. Moreover, we showed that AF-6 was coimmunoprecipitated with ZO-1 from Rat1 cells. Taken together, these results indicate that the Ras-interacting region on AF-6 is structurally similar to that on Raf-1 and on RalGDS and that AF-6 interacts with activated Ras and ZO-1 in vivo. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334923     DOI: 10.1006/bbrc.1999.0731

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Phospholipase C(epsilon): a novel Ras effector.

Authors:  G G Kelley; S E Reks; J M Ondrako; A V Smrcka
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

2.  The Bcr kinase downregulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain.

Authors:  G Radziwill; R A Erdmann; U Margelisch; K Moelling
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

Review 3.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

4.  Under construction: building the macromolecular superstructure and signaling components of an electrical synapse.

Authors:  B D Lynn; Xinbo Li; J I Nagy
Journal:  J Membr Biol       Date:  2012-06-22       Impact factor: 1.843

Review 5.  Blood-brain barrier: structural components and function under physiologic and pathologic conditions.

Authors:  Yuri Persidsky; Servio H Ramirez; James Haorah; Georgette D Kanmogne
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-06       Impact factor: 4.147

Review 6.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  Characterization of nectin processing mediated by presenilin-dependent γ-secretase.

Authors:  Jinsook Kim; Allison Chang; Amanda Dudak; Howard J Federoff; Seung T Lim
Journal:  J Neurochem       Date:  2011-10-20       Impact factor: 5.372

8.  AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).

Authors:  T Taki; H Kano; M Taniwaki; M Sako; M Yanagisawa; Y Hayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

9.  The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.

Authors:  B Boettner; E E Govek; J Cross; L Van Aelst
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

10.  Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival.

Authors:  Satoshi Ohtani; Masanori Terashima; Jun Satoh; Nobutoshi Soeta; Zenichiroh Saze; Seigo Kashimura; Fumihiko Ohsuka; Yutaka Hoshino; Michihiko Kogure; Mitsukazu Gotoh
Journal:  Gastric Cancer       Date:  2009-04-24       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.